American Bio Medica Corp
OTC:ABMC

Watchlist Manager
American Bio Medica Corp Logo
American Bio Medica Corp
OTC:ABMC
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 48.1 USD

Net Margin
American Bio Medica Corp

117.2%
Current
-29%
Average
1.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
117.2%
=
Net Income
850k
/
Revenue
725k

Net Margin Across Competitors

No Stocks Found

American Bio Medica Corp
Glance View

Market Cap
48.1 USD
Industry
Health Care

American Bio Medica Corp. is a biotechnology company. The company is headquartered in Kinderhook, New York. The firm's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. The firm also provides strip manufacturing and assembly and packaging services for a diagnostic test to an unaffiliated third party that sells this product outside the United States and it manufactures a diagnostic product that is sold under a private label by an unaffiliated third party. Its range of products include Products for the Detection of Drugs in Urine, Rapid Drug Screen, RDS InCup, Rapid TOX, Rapid TOX Cup II, Private Label Products, Products for the Detection of Drugs in Oral Fluid, Products for the Detection of Drugs in Oral Fluid, OralStat and other products.

ABMC Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
117.2%
=
Net Income
850k
/
Revenue
725k
What is the Net Margin of American Bio Medica Corp?

Based on American Bio Medica Corp's most recent financial statements, the company has Net Margin of 117.2%.

Back to Top